BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16861647)

  • 1. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity.
    Bera A; Biswas R; Herbert S; Götz F
    Infect Immun; 2006 Aug; 74(8):4598-604. PubMed ID: 16861647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus.
    Bera A; Herbert S; Jakob A; Vollmer W; Götz F
    Mol Microbiol; 2005 Feb; 55(3):778-87. PubMed ID: 15661003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Structure-Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay.
    Pushkaran AC; Nataraj N; Nair N; Götz F; Biswas R; Mohan CG
    J Chem Inf Model; 2015 Apr; 55(4):760-70. PubMed ID: 25774564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci.
    Herbert S; Bera A; Nerz C; Kraus D; Peschel A; Goerke C; Meehl M; Cheung A; Götz F
    PLoS Pathog; 2007 Jul; 3(7):e102. PubMed ID: 17676995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance.
    Hébert L; Courtin P; Torelli R; Sanguinetti M; Chapot-Chartier MP; Auffray Y; Benachour A
    Infect Immun; 2007 Nov; 75(11):5390-8. PubMed ID: 17785473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus.
    Bera A; Biswas R; Herbert S; Kulauzovic E; Weidenmaier C; Peschel A; Götz F
    J Bacteriol; 2007 Jan; 189(1):280-3. PubMed ID: 17085565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the
    Jones CS; Sychantha D; Howell PL; Clarke AJ
    J Biol Chem; 2020 Jun; 295(24):8204-8213. PubMed ID: 32350117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of
    Jones CS; Anderson AC; Clarke AJ
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34480000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cell wall peptidoglycan O-acetylation on the pathogenesis of Staphylococcus aureus in septic arthritis.
    Baranwal G; Mohammad M; Jarneborn A; Reddy BR; Golla A; Chakravarty S; Biswas L; Götz F; Shankarappa S; Jin T; Biswas R
    Int J Med Microbiol; 2017 Oct; 307(7):388-397. PubMed ID: 28802679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of O-acetylation of N-acetylglucosamine: a novel structural variation of bacterial peptidoglycan.
    Bernard E; Rolain T; Courtin P; Guillot A; Langella P; Hols P; Chapot-Chartier MP
    J Biol Chem; 2011 Jul; 286(27):23950-8. PubMed ID: 21586574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori peptidoglycan modifications confer lysozyme resistance and contribute to survival in the host.
    Wang G; Lo LF; Forsberg LS; Maier RJ
    mBio; 2012 Dec; 3(6):e00409-12. PubMed ID: 23221800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural variation in the glycan strands of bacterial peptidoglycan.
    Vollmer W
    FEMS Microbiol Rev; 2008 Mar; 32(2):287-306. PubMed ID: 18070068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci.
    Zhang K; Sparling J; Chow BL; Elsayed S; Hussain Z; Church DL; Gregson DB; Louie T; Conly JM
    J Clin Microbiol; 2004 Nov; 42(11):4947-55. PubMed ID: 15528678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain distribution in extents of lysozyme resistance and O-acetylation of gonococcal peptidoglycan determined by high-performance liquid chromatography.
    Swim SC; Gfell MA; Wilde CE; Rosenthal RS
    Infect Immun; 1983 Nov; 42(2):446-52. PubMed ID: 6417014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay for peptidoglycan O-acetyltransferase: a potential new antibacterial target.
    Moynihan PJ; Clarke AJ
    Anal Biochem; 2013 Aug; 439(2):73-9. PubMed ID: 23660013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacillus subtilis σ(V) confers lysozyme resistance by activation of two cell wall modification pathways, peptidoglycan O-acetylation and D-alanylation of teichoic acids.
    Guariglia-Oropeza V; Helmann JD
    J Bacteriol; 2011 Nov; 193(22):6223-32. PubMed ID: 21926231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OatA, a peptidoglycan O-acetyltransferase involved in Listeria monocytogenes immune escape, is critical for virulence.
    Aubry C; Goulard C; Nahori MA; Cayet N; Decalf J; Sachse M; Boneca IG; Cossart P; Dussurget O
    J Infect Dis; 2011 Sep; 204(5):731-40. PubMed ID: 21844299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance of coagulase-negative staphylococci associated with food and used in starter cultures.
    Resch M; Nagel V; Hertel C
    Int J Food Microbiol; 2008 Sep; 127(1-2):99-104. PubMed ID: 18625535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EslB Is Required for Cell Wall Biosynthesis and Modification in Listeria monocytogenes.
    Rismondo J; Schulz LM; Yacoub M; Wadhawan A; Hoppert M; Dionne MS; Gründling A
    J Bacteriol; 2021 Jan; 203(4):. PubMed ID: 33229460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What distinguishes highly pathogenic staphylococci from medium- and non-pathogenic?
    Rosenstein R; Götz F
    Curr Top Microbiol Immunol; 2013; 358():33-89. PubMed ID: 23224647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.